Try our Advanced Search for more refined results
IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Burns Charest
- K&L Gates
- Andrus Anderson
- McCune Law
- Patterson Belknap
- Gustafson Gluek
- Fiddler Gonzalez
- Ahern and Associates
- Weil Gotshal
- Kirkland & Ellis
- Spiro Harrison
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Lieff Cabraser
- Armstrong Teasdale
- Gibson Dunn
- Morgan Lewis
- Winston & Strawn
- Cozen O'Connor
- Levin Sedran
- Duane Morris
- DLA Piper
- Cleary Gottlieb
- Haynes Boone
- Stevens & Lee
- Fox Rothschild
- Tostrud Law Group
- Edelson Lechtzin
- Wilson Sonsini
- Freshfields
- Skadden Arps
- NastLaw
- Gross & Belsky
- Cole Schotz
- Tycko & Zavareei
- Freedman Boyd
- Girard Sharp
- Steyer Lowenthal
- Troutman
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Morrison & Foerster
- Foley & Lardner
- Krantz & Berman
- Baker Botts
- Lockridge Grindal
- Kohn Swift
- Rosenn Jenkins
- Barrack Rodos
- Obermayer Rebmann
- Schneider Wallace
- DiCello Levitt
- Anselmi & Carvelli
- Saiber LLC
- Cuneo Gilbert
- Stradley Ronon
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- Motley Rice
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Earp Cohn
- Hogan Lovells
- Joseph Saveri Law Firm
- Competition Law Partners
- Seeger Weiss
- King & Spalding
- WilmerHale
- Larson King
- Barrett Law Group
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Polsinelli PC
- Neufeld Scheck
- Spector Roseman
- Robbins Geller
- Neal & Harwell
- Norton Rose
- Goldman Scarlato
- Heins Mills
- Hunt Ortmann
- Hach Rose Schirripa
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Wexler Boley
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Zuckerman Spaeder
- Williams & Connolly
- Lyden Chappell
- Barnes & Thornburg
- Segal McCambridge
- Grabar Law
- Calcaterra Pollack
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Reed Smith
- Napoli Shkolnik
- Carella Byrne
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Faegre Drinker
- Bailey Duquette
- Sills Cummis
- Ballard Spahr
- Debevoise & Plimpton
- Blank Rome
- Goodwin Procter
- Francis Mailman
- O'Melveny & Myers
- Nussbaum Law Group
- Bailey & Glasser
- Venable LLP
- Kaplan Fox
- Steptoe LLP
- Marks O'Neill
- Dugan Law Firm
- Shapiro Arato
- Scott&Scott
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Hangley Aronchick
- Pullman & Comley
- Dilworth Paxson
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- White and Williams
- Wolf Haldenstein
- Tarter Krinsky
- Cotchett Pitre
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Baker & Hostetler
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Boies Schiller
- Crowell & Moring
- Radice Law Firm
- Whatley Kallas
- Cohen Milstein
- Proskauer Rose
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- McDermott Will & Emery
- Zimmerman Reed
- Lowenstein Sandler
- Lewis Brisbois
- Berger Montague
- Glancy Prongay
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Linklaters LLP
- Arnold & Porter
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Humana Inc.
- Impax Laboratories, Inc.
- Sandoz International GmbH
- McKesson Corp.
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Bausch Health Cos. Inc.
- Cencora Inc.
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Glenmark Pharmaceuticals Ltd.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Viatris Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
May 23, 2023
DOJ, Drug Buyers Rip Teva's Criminal Probe Doc Bid In MDL
The government and drug buyers fired back in separate filings in Pennsylvania federal court Tuesday against Teva's bid to use material from a criminal investigation into alleged generic drug price-fixing to defend itself in parallel civil multidistrict litigation over similar allegations, arguing it would undermine prosecutions and create a procedural "mess."
-
March 20, 2023
DOJ Defends Ask For Docs From Drug Price-Fixing MDL
The U.S. Department of Justice defended its bid for discovery materials from multidistrict litigation over generic drug price-fixing claims for use in the government's related criminal prosecutions, rejecting the pharmaceutical companies' claims that the DOJ wanted "unfettered access."
-
March 13, 2023
Pharma Cos. Say Civil Evidence Off Limits In Criminal Case
Pharmaceutical companies that have been facing multidistrict litigation over price-fixing claims are saying absolutely not to an attempt by the U.S. Department of Justice to access civil discovery materials for use in criminal prosecutions tied to the alleged scheme.
-
March 10, 2023
Generic Drug Buyers Get $75M In Price-Fixing Deals Approved
A Pennsylvania federal court signed off on settlements ending price-fixing claims from direct purchasers against Sun Pharmaceutical Industries Inc. and Taro Pharmaceutical Industries USA Inc. in ongoing multidistrict litigation over generic drug prices.
-
February 27, 2023
Drugmakers To Face Price-Fixing Claims From State AGs
In a slew of rulings on Monday, a Pennsylvania federal court rejected most bids from drug companies seeking to nix sweeping price-fixing conspiracy allegations from a group of state attorneys general.
-
November 09, 2022
Drug Buyers, States Want To Depose Indicted Ex-Taro Exec
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
-
June 07, 2022
AGs' Disgorgement Claim Axed In Drug Price-Fixing Case
The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
-
May 25, 2022
Generic Distributors Slip Indirect Reseller Price-Fixing Claims
A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
-
May 20, 2022
Drugmakers Say Pa. AG Not Producing Generic-Drug Docs
Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.
-
May 11, 2022
Settlements Worth $86M OK'd In Drug Price-Fixing MDL
Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.